Literature DB >> 1755942

C1: molecular interactions with activating systems.

R B Sim1, K B Reid.   

Abstract

The molecular events controlling complement activation have been gradually unravelled over the past three decades, stimulated by improved isolation procedures and a better understanding of the roles of individual proteins. In this review, Bob Sim and Ken Reid examine the interactions between C1q and its numerous ligands in the initiation of the classical pathway cascade.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1755942     DOI: 10.1016/0167-5699(91)90004-D

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  12 in total

1.  Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype.

Authors:  Jing Qi Feng; Krystyna Mozdzanowska; Walter Gerhard
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Antibodies have the intrinsic capacity to destroy antigens.

Authors:  A D Wentworth; L H Jones; P Wentworth; K D Janda; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 3.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

4.  Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52.

Authors:  S Redpath; T Michaelsen; I Sandlie; M R Clark
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

Review 5.  Collectins, collectin receptors and the lectin pathway of complement activation.

Authors:  R Malhotra; J Lu; U Holmskov; R B Sim
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

Review 6.  Are anti-C1q antibodies different from other SLE autoantibodies?

Authors:  Matthew C Pickering; Marina Botto
Journal:  Nat Rev Rheumatol       Date:  2010-04-27       Impact factor: 20.543

7.  Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.

Authors:  J C Magee; B H Collins; R C Harland; B J Lindman; R R Bollinger; M M Frank; J L Platt
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

8.  Recombinant bovine conglutinin, lacking the N-terminal and collagenous domains, has less conglutination activity but is able to inhibit haemagglutination by influenza A virus.

Authors:  S Eda; Y Suzuki; T Kase; T Kawai; K Ohtani; T Sakamoto; T Kurimura; N Wakamiya
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

9.  Surfactant protein D binding to alveolar macrophages.

Authors:  K Miyamura; L E Leigh; J Lu; J Hopkin; A López Bernal; K B Reid
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

10.  Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.

Authors:  R Veerhuis; P van der Valk; I Janssen; S S Zhan; W E Van Nostrand; P Eikelenboom
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.